Fu-Xiang Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fu-Xiang Zhou has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Cong-Hua Xie
Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China
4 shared publications - Yun-Feng Zhou
Zhongnan Hospital of Wuhan University
4 shared publications Desheng Hu
Hubei Tumor Hospital, Wuhan, China
2 shared publicationsShi-Quan Liu
2 shared publicationsCheng-Hu Huang
1 shared publicationChuang-Ying Xiao
1 shared publication
Latest Publications
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e17523
Clinical evaluation of circulating tumor cells in locally advanced nasopharyngeal carcinoma: A prospective study.
E17523 Background: Circulating tumor cells (CTCs) have been showed to correlate with curative effects and prognosis in many cancers, but there are few data describing the importance of CTCs in nasopharyngeal carcinoma (NPC). Our aim was to prospect the karyotyping of CTCs and the correlation between CTCs and clinical response in patients with locally advanced NPC. Methods: Serum was collected in 82 patients with locally advanced NPC. CTC was measured by negative enrichment with immunostaining of CD45, DAPI and imFISH with the centromere of chromosome 8 probe (CEP8) method. Cells with CD45-/DAPI+/CEP8 ≥3 were defined as positive CTCs and the karyotyping of chromosome 8 in CTCs were identified as triploidy, tetraploidy and multiploidy. Patients were treated with 2 cycles of induction chemotherapy followed by concurrent chemoradiotherapy according to the clinical trial (NCT 02562599). CTC was also measured after each cycle of chemotherapy. Clinial response was classified according to the Response Evaluation Criteria in Solid Tumours (RECIST 1.1) criteria. Results: Positive CTCs were detected in 42 of 82 patients prior to treatment. They were independent with age, sex, smoking and clinical stages. Continuous CTC detection of 30 enrolled patients with positive CTCs showed that the ratio of CTCs and CTCs with different ploidies significantly decreased after therapy (P < 0.05). Although the change was not correlated with clinical response (P = 0.054), the decreases in CTCs count of patients who had complete response (CR) to the treatment were significant (P < 0.05), while the decreases of CTCs count of patients who had partial response (PR) were not (P > 0.05). Further analysis indicated that CR patients had fewer tetraploidy CTCs prior to the therapy than PR patients (P < 0.05). Moreover, tetraploidy CTCs count also indicated a positive prediction value for clinical response to treatment according to maximum likelihood estimation (P = 0.045, 95%CI [1.032,18.060]). Conclusions: The decrease of CTCs is correlated with a better therapeutic efficacy in patients with locally advanced NPC and the number of tetraploidy CTCs before treatment could be used as a predictive factor for clinical outcomes.
- 20 May 2017
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , e17523
Clinical evaluation of circulating tumor cells in locally advanced nasopharyngeal carcinoma: A prospective study.
E17523 Background: Circulating tumor cells (CTCs) have been showed to correlate with curative effects and prognosis in many cancers, but there are few data describing the importance of CTCs in nasopharyngeal carcinoma (NPC). Our aim was to prospect the karyotyping of CTCs and the correlation between CTCs and clinical response in patients with locally advanced NPC. Methods: Serum was collected in 82 patients with locally advanced NPC. CTC was measured by negative enrichment with immunostaining of CD45, DAPI and imFISH with the centromere of chromosome 8 probe (CEP8) method. Cells with CD45-/DAPI+/CEP8 ≥3 were defined as positive CTCs and the karyotyping of chromosome 8 in CTCs were identified as triploidy, tetraploidy and multiploidy. Patients were treated with 2 cycles of induction chemotherapy followed by concurrent chemoradiotherapy according to the clinical trial (NCT 02562599). CTC was also measured after each cycle of chemotherapy. Clinial response was classified according to the Response Evaluation Criteria in Solid Tumours (RECIST 1.1) criteria. Results: Positive CTCs were detected in 42 of 82 patients prior to treatment. They were independent with age, sex, smoking and clinical stages. Continuous CTC detection of 30 enrolled patients with positive CTCs showed that the ratio of CTCs and CTCs with different ploidies significantly decreased after therapy (P < 0.05). Although the change was not correlated with clinical response (P = 0.054), the decreases in CTCs count of patients who had complete response (CR) to the treatment were significant (P < 0.05), while the decreases of CTCs count of patients who had partial response (PR) were not (P > 0.05). Further analysis indicated that CR patients had fewer tetraploidy CTCs prior to the therapy than PR patients (P < 0.05). Moreover, tetraploidy CTCs count also indicated a positive prediction value for clinical response to treatment according to maximum likelihood estimation (P = 0.045, 95%CI [1.032,18.060]). Conclusions: The decrease of CTCs is correlated with a better therapeutic efficacy in patients with locally advanced NPC and the number of tetraploidy CTCs before treatment could be used as a predictive factor for clinical outcomes.
- 1 September 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 465 (1) , 137-144
The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121
- 1 September 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 465 (1) , 137-144
The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121
- 1 October 2008
- Vol. 30 (10) , 733-6
[hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice].
To explore the therapeutic efficiency of human telomerase reverse transcriptase promoter (hTERTp) mediated horseradish peroxidase (HRP) catalyzed effects of indole-3-acetic (IAA) on laryngeal squamous cell carcinoma with different radiosensitivity in vivo. Human laryngeal squamous cell carcinoma Hep-2 and Hep-2R cells were transplanted into nude mice. After growing to about 30 approximately 50 mm3, the tumor-bearing mice were randomly divided into eight groups: Hep-2 line: combined group (A), gene group (B), radiation group (C) and blank group (D); Hep-2R line: combined group (AR), gene group (BR), radiation group (CR) and blank group (DR). The phTERTp-HRP was delivered by intratumoral injection and the IAA by intraperitoneal injection, combined with 2 Gy daily radiation to a total dose of 30 Gy. The tumor volume was recorded. The cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay. The expression of HRP protein was detected by AP immunohistochemisty. The tumor growth of combined groups was attenuated significantly and the tumor volume of Hep-2R blank group was the largest. The inhibition rate of each group was: A: 54.8%, B: 10.0%, C: 31.9%; AR: 52.7%, BR: 24.8%, CR: 17.0%. In the combined groups, necrosis and apoptosis of tumor cells were observed under the light microscope and the apoptotic index [A (16.6 +/- 1.3)% vs. AR (17.6 +/- 1.3)%] of tumor cells was highest (P < 0.05). The HRP protein expression of BR (33.3 +/- 8.9)% was higher than that of B (21.9 +/- 5.7)%, which was directly up-regulated in the tumors (45.0% vs. 54.8%, P < 0.05) after radiation. In the Hep-2- and Hep-2R-transplantation tumors in nude mice, hTERTp can be induced by radiation and enhance the expression of horseradish peroxidase (HRP) gene according to telomerase activity. hTERTp-HRP/IAA system, which has synergistic effects with radiation and inhibits the tumor growth by induction of apoptosis and necrosis, may be a new gene-radiation strategy for the treatment of laryngeal carcinoma.
- 1 October 2008
- Vol. 30 (10) , 733-6
[hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice].
To explore the therapeutic efficiency of human telomerase reverse transcriptase promoter (hTERTp) mediated horseradish peroxidase (HRP) catalyzed effects of indole-3-acetic (IAA) on laryngeal squamous cell carcinoma with different radiosensitivity in vivo. Human laryngeal squamous cell carcinoma Hep-2 and Hep-2R cells were transplanted into nude mice. After growing to about 30 approximately 50 mm3, the tumor-bearing mice were randomly divided into eight groups: Hep-2 line: combined group (A), gene group (B), radiation group (C) and blank group (D); Hep-2R line: combined group (AR), gene group (BR), radiation group (CR) and blank group (DR). The phTERTp-HRP was delivered by intratumoral injection and the IAA by intraperitoneal injection, combined with 2 Gy daily radiation to a total dose of 30 Gy. The tumor volume was recorded. The cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay. The expression of HRP protein was detected by AP immunohistochemisty. The tumor growth of combined groups was attenuated significantly and the tumor volume of Hep-2R blank group was the largest. The inhibition rate of each group was: A: 54.8%, B: 10.0%, C: 31.9%; AR: 52.7%, BR: 24.8%, CR: 17.0%. In the combined groups, necrosis and apoptosis of tumor cells were observed under the light microscope and the apoptotic index [A (16.6 +/- 1.3)% vs. AR (17.6 +/- 1.3)%] of tumor cells was highest (P < 0.05). The HRP protein expression of BR (33.3 +/- 8.9)% was higher than that of B (21.9 +/- 5.7)%, which was directly up-regulated in the tumors (45.0% vs. 54.8%, P < 0.05) after radiation. In the Hep-2- and Hep-2R-transplantation tumors in nude mice, hTERTp can be induced by radiation and enhance the expression of horseradish peroxidase (HRP) gene according to telomerase activity. hTERTp-HRP/IAA system, which has synergistic effects with radiation and inhibits the tumor growth by induction of apoptosis and necrosis, may be a new gene-radiation strategy for the treatment of laryngeal carcinoma.
- 1 March 2007
- Vol. 41 (2) , 105-9
[Protection of Angelica sinensis against radiation-induced pulmonary fibrosis in mice].
To evaluate the Angelica Sinensis as a protecting agent affecting the radiation-induced pulmonary fibrosis in an animal model, The thoraces of C57BL/6 mice were exposed to either sham irradiation or single fraction of 12 Gy. Four groups were defined: that received neither irradiation nor Angelica Sinensis (N group), that received Angelica Sinensis but no irradiation (A group), that underwent irradiation without Angelica Sinensis (NX group) and that received both Angelica Sinensis and irradiation (AX group). Mice were sacrificed at 1, 24, 72 hours and 1, 2, 4, 8, 16, 24 weeks post-irradiation. The lungs tissue were removed and processed for definitive analysis, including hydroxyproline content, HE and Masson staining, and the TGF-beta1, (Transforming Growth Factor beta1, TGF-beta1) mRNA expressions. Compared with N and A group, there was some differences in the AX group, but a significant histological and pathologic changes in NX group. Non-irradiated groups (N and A group) exhibited low levels of hydroxyproline (0.775 +/- 0.024) microg/mg and (0.751 +/- 0.034) microg/mg, and there was a significantly elevated level of hydroxyproline in NX group (0.875 +/- 0.009) microg/mg (P < 0.05). AX group (0.782 +/- 0.010) microg/mg was in between the non-irradiated groups (N and A group) and the radiation-only group (NX group), and the difference between AX group and NX group was significant (P < 0.01). The results of real-time quantitative RT-PCR showed that the relative mRNA expressions of cytokine TGF-beta1 in NX group(249.655 +/- 16.320) was significantly higher than that in group A (1.254 +/- 0.061) and N (1.324 +/- 0.057) (P < 0.01), and that in AX group (108.076 +/- 9.870) decreased than that of NX group (P < 0.01). An animal model of mice with radiation-induced lung injure was established successfully. This study has demonstrated that Angelica sinensis in Hibits the progress of radiation-induced pulmonary fibrosis, Possibly by down-regulating the expression of the proinflammatory cytokine Tgfb1. These data suggest that Angelica sinensis maybe useful in preventing and/or treating radiation-induced pulmonary fibrosis in the clinic.
- 1 March 2007
- Vol. 41 (2) , 105-9
[Protection of Angelica sinensis against radiation-induced pulmonary fibrosis in mice].
To evaluate the Angelica Sinensis as a protecting agent affecting the radiation-induced pulmonary fibrosis in an animal model, The thoraces of C57BL/6 mice were exposed to either sham irradiation or single fraction of 12 Gy. Four groups were defined: that received neither irradiation nor Angelica Sinensis (N group), that received Angelica Sinensis but no irradiation (A group), that underwent irradiation without Angelica Sinensis (NX group) and that received both Angelica Sinensis and irradiation (AX group). Mice were sacrificed at 1, 24, 72 hours and 1, 2, 4, 8, 16, 24 weeks post-irradiation. The lungs tissue were removed and processed for definitive analysis, including hydroxyproline content, HE and Masson staining, and the TGF-beta1, (Transforming Growth Factor beta1, TGF-beta1) mRNA expressions. Compared with N and A group, there was some differences in the AX group, but a significant histological and pathologic changes in NX group. Non-irradiated groups (N and A group) exhibited low levels of hydroxyproline (0.775 +/- 0.024) microg/mg and (0.751 +/- 0.034) microg/mg, and there was a significantly elevated level of hydroxyproline in NX group (0.875 +/- 0.009) microg/mg (P < 0.05). AX group (0.782 +/- 0.010) microg/mg was in between the non-irradiated groups (N and A group) and the radiation-only group (NX group), and the difference between AX group and NX group was significant (P < 0.01). The results of real-time quantitative RT-PCR showed that the relative mRNA expressions of cytokine TGF-beta1 in NX group(249.655 +/- 16.320) was significantly higher than that in group A (1.254 +/- 0.061) and N (1.324 +/- 0.057) (P < 0.01), and that in AX group (108.076 +/- 9.870) decreased than that of NX group (P < 0.01). An animal model of mice with radiation-induced lung injure was established successfully. This study has demonstrated that Angelica sinensis in Hibits the progress of radiation-induced pulmonary fibrosis, Possibly by down-regulating the expression of the proinflammatory cytokine Tgfb1. These data suggest that Angelica sinensis maybe useful in preventing and/or treating radiation-induced pulmonary fibrosis in the clinic.
- 1 January 2007
- Vol. 29 (1) , 9-13
[Effective inhibition of hTERT expression by RNA interference on the radiosensitivity of human laryngeal cancer Hep-2 cell line].
To construct an eukaryotic expression vector of human telomerase reverse transcriptase (hTERT) gene specific shRNA, and investigate the effect of pshRNA-hTERT combined with gamma-irradiation on cell survival and telomerase activity. According to the coding sequence of hTERT mRNA, the target of RNAi was designed, and recombinant expression plasmid pshRNA-hTERT was constructed. The vector was transfected into Hep-2 cells. The radiosensitivity of Hep-2 cells was determined by clonogenic assay. Telomeric repeat amplification protocol (TRAP-PCR-ELISA) was used to observe the telomerase activity in each group. Results Recombinant expression vector pshRNA-hTERT was successfully transfected into Hep-2 cells. The hTERT expression inhibition rate reached 60. 8%. pshRNA-hTERT not only inhibited telomerase activity of Hep-2, but also inhibited the raise of telomerase activity induced by gamma-irradiation. Exposure of Hep-2 cells to pshRNA-hTERT for 24 hrs before irradiation resulted in a decrease in mean surviving fraction of Hep-2 cells compared with cells of group with irradiation alone (67. 7% vs 85. 7%, P <0. 05) . RNAi showed a significant inhibitory effect to the expression of hTERT. The results indicate that pshRNA-hTERT can effectively inhibit telomerase activity of Hep-2 cells treated or untreated with 2 Gy gamma-irradiation and significantly enhance the radiosensitivity of Hep-2 cells in vitro. The role of radiosensitization of pshRNA-hTERT may be related with the inhibition of telomerase activity.
- 1 January 2007
- Vol. 29 (1) , 9-13
[Effective inhibition of hTERT expression by RNA interference on the radiosensitivity of human laryngeal cancer Hep-2 cell line].
To construct an eukaryotic expression vector of human telomerase reverse transcriptase (hTERT) gene specific shRNA, and investigate the effect of pshRNA-hTERT combined with gamma-irradiation on cell survival and telomerase activity. According to the coding sequence of hTERT mRNA, the target of RNAi was designed, and recombinant expression plasmid pshRNA-hTERT was constructed. The vector was transfected into Hep-2 cells. The radiosensitivity of Hep-2 cells was determined by clonogenic assay. Telomeric repeat amplification protocol (TRAP-PCR-ELISA) was used to observe the telomerase activity in each group. Results Recombinant expression vector pshRNA-hTERT was successfully transfected into Hep-2 cells. The hTERT expression inhibition rate reached 60. 8%. pshRNA-hTERT not only inhibited telomerase activity of Hep-2, but also inhibited the raise of telomerase activity induced by gamma-irradiation. Exposure of Hep-2 cells to pshRNA-hTERT for 24 hrs before irradiation resulted in a decrease in mean surviving fraction of Hep-2 cells compared with cells of group with irradiation alone (67. 7% vs 85. 7%, P <0. 05) . RNAi showed a significant inhibitory effect to the expression of hTERT. The results indicate that pshRNA-hTERT can effectively inhibit telomerase activity of Hep-2 cells treated or untreated with 2 Gy gamma-irradiation and significantly enhance the radiosensitivity of Hep-2 cells in vitro. The role of radiosensitization of pshRNA-hTERT may be related with the inhibition of telomerase activity.
- 1 June 2005
- Vol. 24 (6)
[Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
Many studies showed that telomere length and telomerase activity closely correlate with proliferation and malignant degree of tumor cells, and both of them might be involved in the repair of radiation-induced DNA damage. So it was speculated that telomere length and telomerase activity maybe correlate to radiosensitivity of carcinoma cells. This study was designed to investigate the correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cell line Hep-2.
- 1 June 2005
- Vol. 24 (6)
[Correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cells].
Many studies showed that telomere length and telomerase activity closely correlate with proliferation and malignant degree of tumor cells, and both of them might be involved in the repair of radiation-induced DNA damage. So it was speculated that telomere length and telomerase activity maybe correlate to radiosensitivity of carcinoma cells. This study was designed to investigate the correlations of telomere length and telomerase activity to radiosensitivity of human laryngeal squamous carcinoma cell line Hep-2.